Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study.

about

Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study.

Item

http://www.wikidata.org/entity/Q55195946

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Secukinumab provides rapid and ...... sults from the FUTURE 2 study.

@en

Secukinumab provides rapid and ...... sults from the FUTURE 2 study.

@nl

type

Item

label

Secukinumab provides rapid and ...... sults from the FUTURE 2 study.

@en

Secukinumab provides rapid and ...... sults from the FUTURE 2 study.

@nl

prefLabel

Secukinumab provides rapid and ...... sults from the FUTURE 2 study.

@en

Secukinumab provides rapid and ...... sults from the FUTURE 2 study.

@nl

P1476

Secukinumab provides rapid and ...... sults from the FUTURE 2 study.

@en

P2093

Bruce Kirkham

http://www.w3.org/2001/XMLSchema#string

FUTURE 2 Study Group

http://www.w3.org/2001/XMLSchema#string

Iain B McInnes

http://www.w3.org/2001/XMLSchema#string

Kunal K Gandhi

http://www.w3.org/2001/XMLSchema#string

Luminita Pricop

http://www.w3.org/2001/XMLSchema#string

Nicole Williams

http://www.w3.org/2001/XMLSchema#string

Philip J Mease

http://www.w3.org/2001/XMLSchema#string

Steffen M Jugl

http://www.w3.org/2001/XMLSchema#string

Todd Fox

http://www.w3.org/2001/XMLSchema#string

Vibeke Strand

http://www.w3.org/2001/XMLSchema#string

P2860

Psoriatic Arthritis.

The burden of psoriatic arthritis: a literature review from a global health systems perspective.

A comparison of disease burden in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis

US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey.

Psoriatic Arthritis and Burden of Disease: Patient Perspectives from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey.

The impact of arthritis and joint pain on individual healthcare expenditures: findings from the Medical Expenditure Panel Survey (MEPS), 2011.

Work disability in psoriatic arthritis: a systematic review.

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis.

Secukinumab for Long-Term Treatment of Psoriatic Arthritis: A Two-Year Followup From a Phase III, Randomized, Double-Blind Placebo-Controlled Study.

Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis: results from a randomised phase III trial (FUTURE 1).

P2888

s13075-018-1610-3

P304

113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13075-018-1610-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Georg Schett

P577

2018-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29880010

http://www.w3.org/2001/XMLSchema#string

P932

5992664

http://www.w3.org/2001/XMLSchema#string